Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.09 USD
Change Today +0.03 / 2.83%
Volume 364.2K
ENZN On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 5:20 PM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at enzon pharmaceuticals inc (ENZN)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
There is no Company Insiders data available.

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Jonathan Christodoro 64 RelationshipsChairman of the BoardEnzon Pharmaceuticals Inc.37
Jennifer McNealey 2 RelationshipsMember of the Board of DirectorsEnzon Pharmaceuticals Inc.41
Odysseas Kostas M.D. 2 RelationshipsMember of the Board of DirectorsEnzon Pharmaceuticals Inc.39
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENZN:US $1.09 USD +0.03

ENZN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abzena PLC 83.25 GBp 0.00
Nektar Therapeutics $10.82 USD -0.18
Onxeo €5.23 EUR -0.08
Regulus Therapeutics Inc $17.45 USD +0.51
Veloxis Pharmaceuticals A/S kr0.90 DKK +0.005
View Industry Companies
 

Industry Analysis

ENZN

Industry Average

Valuation ENZN Industry Range
Price/Earnings 1.6x
Price/Sales 1.5x
Price/Book 1.6x
Price/Cash Flow 1.6x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.